Zacks Investment Research upgraded shares of Koninklijke DSM NV (OTCMKTS:RDSMY) from a sell rating to a buy rating in a research note released on Tuesday. They currently have $19.00 target price on the stock.
According to Zacks, “DSM N V ADR is involved in the Chemicals Industry. Their main focus is on base materials, performance materials, materials processing, base chemicals and fine chemicals and coating resins. They are also involved in the exploration and development of oil and natural gas deposits in the North Sea, as well as the licensing of chemical technology and know-how; in addition the company produces ingredients for bakery products. DSM is a world market leader in a number of products, including caprolactam, melamine and EPDM synthetic rubber. “
Koninklijke DSM NV (OTCMKTS:RDSMY) opened at 16.32 on Tuesday. The stock has a market cap of $11.39 billion, a price-to-earnings ratio of 38.38 and a beta of 1.44. The company has a 50 day moving average price of $17.03 and a 200 day moving average price of $15.69. Koninklijke DSM NV has a 52 week low of $11.33 and a 52 week high of $17.88.
Koninklijke DSM NV Company Profile